BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 19479756)

  • 1. Pyrazolo[3,4-d]pyrimidine derivatives as COX-2 selective inhibitors: synthesis and molecular modelling studies.
    Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Plescia S; Cusimano MG
    Arch Pharm (Weinheim); 2009 Jun; 342(6):321-6. PubMed ID: 19479756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrazolobenzotriazinone derivatives as COX inhibitors: synthesis, biological activity, and molecular-modeling studies.
    Raffa D; Migliara O; Maggio B; Plescia F; Cascioferro S; Cusimano MG; Tringali G; Cannizzaro C; Plescia F
    Arch Pharm (Weinheim); 2010 Nov; 343(11-12):631-8. PubMed ID: 21110338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of N-substituted-3,5-diphenyl-2-pyrazoline derivatives as cyclooxygenase (COX-2) inhibitors.
    Fioravanti R; Bolasco A; Manna F; Rossi F; Orallo F; Ortuso F; Alcaro S; Cirilli R
    Eur J Med Chem; 2010 Dec; 45(12):6135-8. PubMed ID: 20974503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
    Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and SAR of heteroaryl-phenyl-substituted pyrazole derivatives as highly selective and potent canine COX-2 inhibitors.
    Cheng H; Lundy DeMello KM; Li J; Sakya SM; Ando K; Kawamura K; Kato T; Rafka RJ; Jaynes BH; Ziegler CB; Stevens R; Lund LA; Mann DW; Kilroy C; Haven ML; Nimz EL; Dutra JK; Li C; Minich ML; Kolosko NL; Petras C; Silvia AM; Seibel SB
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2076-80. PubMed ID: 16464588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
    Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
    Azam MA; Dharanya L; Mehta CC; Sachdeva S
    Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological evaluation and molecular modeling study of pyrazole and pyrazoline derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Part 2.
    El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; ElTahir KE
    Bioorg Med Chem; 2012 May; 20(10):3306-16. PubMed ID: 22516672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Synthesis of new derivatives of pyrazole and pyrazolo[3,4-d]pyrimidine].
    Machoń Z; Witkiewicz K
    Acta Pol Pharm; 1985; 42(6):516-20. PubMed ID: 3835811
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and antimicrobial activity of novel pyrazolo[3,4-d]pyrimidin derivatives.
    Khobragade CN; Bodade RG; Konda SG; Dawane BS; Manwar AV
    Eur J Med Chem; 2010 Apr; 45(4):1635-8. PubMed ID: 20096486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of some thiazolyl and thiadiazolyl derivatives of 1H-pyrazole as anti-inflammatory antimicrobial agents.
    Bekhit AA; Ashour HM; Abdel Ghany YS; Bekhit Ael-D; Baraka A
    Eur J Med Chem; 2008 Mar; 43(3):456-63. PubMed ID: 17532544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel pyrazole compounds.
    Youssef AM; Neeland EG; Villanueva EB; White MS; El-Ashmawy IM; Patrick B; Klegeris A; Abd-El-Aziz AS
    Bioorg Med Chem; 2010 Aug; 18(15):5685-96. PubMed ID: 20609589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antiinflammatory activity of 7-oxo-1H,7H-pyrazolo[1,5-a]pyrimidine-6-N-pyridylcarboxamides.
    Doria G; Passarotti C; Sala R; Magrini R; Sberze P; Tibolla M; Buttinoni A; Ferrari M; Tremolada L
    Farmaco Sci; 1985 Nov; 40(11):808-17. PubMed ID: 4085643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of some novel pyrazolo[3,4-d]pyrimidine derivatives as potential antimicrobial agents.
    Holla BS; Mahalinga M; Karthikeyan MS; Akberali PM; Shetty NS
    Bioorg Med Chem; 2006 Mar; 14(6):2040-7. PubMed ID: 16310361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents.
    El-Sayed Ali T
    Eur J Med Chem; 2009 Nov; 44(11):4385-92. PubMed ID: 19586688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 4,5-diaryl-1H-pyrazole-3-ol derivatives as potential COX-2 inhibitors.
    Patel MV; Bell R; Majest S; Henry R; Kolasa T
    J Org Chem; 2004 Oct; 69(21):7058-65. PubMed ID: 15471453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Heteroatom substituted pyrazoles as canine COX-2 inhibitors. Part III: molecular modeling studies on binding contribution of 1-(5-methylsulfonyl)pyrid-2-yl and 4-nitrile.
    Sakya SM; Hou X; Minich ML; Rast B; Shavnya A; DeMello KM; Cheng H; Li J; Jaynes BH; Mann DW; Petras CF; Seibel SB; Haven ML
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1067-72. PubMed ID: 17126015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
    Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
    Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation, and enzyme docking simulations of 1,5-diarylpyrrole-3-alkoxyethyl ethers as selective cyclooxygenase-2 inhibitors endowed with anti-inflammatory and antinociceptive activity.
    Anzini M; Rovini M; Cappelli A; Vomero S; Manetti F; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Giordani A; Makovec F; Anzellotti P; Patrignani P; Biava M
    J Med Chem; 2008 Aug; 51(15):4476-81. PubMed ID: 18598017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective inhibition of cyclooxygenase and lipooxygenase pathways in follicle rupture and ovulation in the rat.
    Gaytán M; Bellido C; Morales C; Sánchez-Criado JE; Gaytán F
    Reproduction; 2006 Oct; 132(4):571-7. PubMed ID: 17008468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.